The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 3,656,250 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | |||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 5,467,500 | 22,500 | SH | SOLE | 22,500 | 0 | 0 | |||
ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 16,621,200 | 68,400 | SH | Put | SOLE | 68,400 | 0 | 0 | ||
AN2 THERAPEUTICS INC | COM | 037326105 | 471,562 | 219,331 | SH | SOLE | 219,331 | 0 | 0 | |||
ANNEXON INC | COM | 03589W102 | 1,519,000 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | |||
ANNEXON INC | COM | 03589W102 | 1,051,050 | 214,500 | SH | Call | SOLE | 214,500 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 5,178,600 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | |||
ARROWHEAD PHARMACEUTICALS IN | COM | 04280A100 | 909,650 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | |||
ARVINAS INC | COM | 04335A105 | 1,996,500 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | |||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 11,827,010 | 86,721 | SH | SOLE | 86,721 | 0 | 0 | |||
ATYR PHARMA INC | COM NEW | 002120202 | 1,248,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | |||
AXSOME THERAPEUTICS INC | COM | 05464T104 | 12,075,000 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
BIOHAVEN LTD | COM | G1110E107 | 17,007,900 | 490,000 | SH | SOLE | 490,000 | 0 | 0 | |||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 4,311,200 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | |||
BRIDGEBIO PHARMA INC | COM | 10806X102 | 3,546,200 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | |||
CABALETTA BIO INC | COM | 12674W109 | 2,774,325 | 370,899 | SH | SOLE | 370,899 | 0 | 0 | |||
CG ONCOLOGY INC | COM | 156944100 | 8,208,200 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | |||
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | 7,918,750 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | |||
CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | 10,749,600 | 240,000 | SH | SOLE | 240,000 | 0 | 0 | |||
CYTOKINETICS INC | COM NEW | 23282W605 | 1,798,776 | 33,200 | SH | SOLE | 33,200 | 0 | 0 | |||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 366,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
ELEVATION ONCOLOGY INC | COM | 28623U101 | 1,620,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | |||
ENGENE HOLDINGS INC | COM | 29286M105 | 3,963,721 | 420,331 | SH | SOLE | 420,331 | 0 | 0 | |||
HELIX ACQUISITION CORP II | CL A ORD SHS | G4444H101 | 3,066,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
IMMUNOVANT INC | COM | 45258J102 | 6,864,000 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | |||
INSMED INC | COM PAR $.01 | 457669307 | 4,355,000 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | |||
INSMED INC | COM PAR $.01 | 457669307 | 13,400,000 | 200,000 | SH | Call | SOLE | 200,000 | 0 | 0 | ||
INTELLIA THERAPEUTICS INC | COM | 45826J105 | 559,500 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | |||
INTRA-CELLULAR THERAPIES INC | COM | 46116X101 | 684,900 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
JANUX THERAPEUTICS INC | COM | 47103J105 | 2,094,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | |||
KORRO BIO INC | COM | 500946108 | 3,387,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | |||
KRYSTAL BIOTECH INC | COM | 501147102 | 1,560,940 | 8,500 | SH | SOLE | 8,500 | 0 | 0 | |||
MACROGENICS INC | COM | 556099109 | 637,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 13,191,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
NEUROGENE INC | COM | 64135M105 | 2,547,300 | 70,000 | SH | SOLE | 70,000 | 0 | 0 | |||
NUVATION BIO INC | COM CL A | 67080N101 | 3,358,000 | 1,150,000 | SH | SOLE | 1,150,000 | 0 | 0 | |||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 5,951,000 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | |||
PERSPECTIVE THERAPEUTICS INC | COM NEW | 46489V302 | 9,222,250 | 925,000 | SH | SOLE | 925,000 | 0 | 0 | |||
PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 6,180,000 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | |||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 607,500 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | |||
PROQR THRAPEUTICS N V | SHS EURO | N71542109 | 1,494,000 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | |||
PTC THERAPEUTICS INC | COM | 69366J200 | 581,020 | 19,000 | SH | SOLE | 19,000 | 0 | 0 | |||
RAPT THERAPEUTICS INC | COM | 75382E109 | 915,000 | 300,000 | SH | Call | SOLE | 300,000 | 0 | 0 | ||
REGENXBIO INC | COM | 75901B107 | 1,989,000 | 170,000 | SH | SOLE | 170,000 | 0 | 0 | |||
REPLIMUNE GROUP INC | COM | 76029N106 | 4,050,000 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | |||
REVANCE THERAPEUTICS INC | COM | 761330109 | 578,250 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | |||
REZOLUTE INC | COM NEW | 76200L309 | 6,112,454 | 1,421,501 | SH | SOLE | 1,421,501 | 0 | 0 | |||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 4,819,951 | 117,388 | SH | SOLE | 117,388 | 0 | 0 | |||
ROIVANT SCIENCES LTD | SHS | G76279101 | 10,570,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | |||
SAGIMET BIOSCIENCES INC | COM SER A | 786700104 | 769,500 | 225,000 | SH | SOLE | 225,000 | 0 | 0 | |||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 8,690,000 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | |||
SAVARA INC | COM | 805111101 | 4,235,030 | 1,050,876 | SH | SOLE | 1,050,876 | 0 | 0 | |||
SOLENO THERAPEUTICS INC | COM | 834203309 | 12,240,000 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | |||
SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | 5,883,072 | 250,237 | SH | SOLE | 250,237 | 0 | 0 | |||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 7,185,500 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 6,387,300 | 235,000 | SH | SOLE | 235,000 | 0 | 0 | |||
TAYSHA GENE THERAPIES INC | COM SHS | 877619106 | 2,800,000 | 1,250,000 | SH | SOLE | 1,250,000 | 0 | 0 | |||
TENAYA THERAPEUTICS INC | COM | 87990A106 | 4,185,000 | 1,350,000 | SH | SOLE | 1,350,000 | 0 | 0 | |||
TG THERAPEUTICS INC | COM | 88322Q108 | 8,895,000 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | |||
VAXCYTE INC | COM | 92243G108 | 11,326,500 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | |||
VIKING THERAPEUTICS INC | COM | 92686J106 | 5,035,950 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | |||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 7,646,081 | 587,708 | SH | SOLE | 587,708 | 0 | 0 | |||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 998,000 | 200,000 | SH | SOLE | 200,000 | 0 | 0 |